Galectin Therapeutics to Present at 30th Annual ROTH Conference
February 28, 2018 16:35 ET
|
Galectin Therapeutics Inc.
NORCROSS, Ga., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Peter G. Traber,...
Galectin Therapeutics to Present at BIO CEO & Investor Conference
February 06, 2018 09:15 ET
|
Galectin Therapeutics Inc.
NORCROSS, Ga., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Peter G. Traber,...
Galectin Therapeutics to Present at BIO CEO & Investor Conference
February 08, 2017 08:30 ET
|
Galectin Therapeutics
NORCROSS, Ga., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Harold...
Summit Therapeutics to Present at 18th Annual BIO CEO & Investor Conference
February 03, 2016 07:00 ET
|
Summit Therapeutics plc
OXFORD, United Kingdom, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (LSE:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular...
Atossa Genetics to Present at the FSX Dallas Investor Conference
February 05, 2013 14:09 ET
|
Atossa Genetics
SEATTLE, WA--(Marketwire - Feb 5, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, CFO and General Counsel, will present...
Atossa Genetics to Present at the 15th Annual BIO CEO and Investor Conference
January 28, 2013 08:15 ET
|
Atossa Genetics
SEATTLE, WA--(Marketwire - Jan 28, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Dr. Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and...
Elite Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference on February 14, 2011
February 08, 2011 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 8, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing...